Worldwide Webinar Series:

Impact of Modeling & Simulation in Drug Development

Rosa’s Worldwide Webinar Series fosters the adoption of modeling and simulation by informing a broad audience about the strategic impact it can have on all aspects of research and development.

Since its inception in 2011, this complimentary, monthly series has featured select speakers from academia, industry, Rosa client companies, and Rosa itself. The series has drawn many thousands of attendees worldwide from all drug development disciplines.

Sign up to receive Webinar and QSP News Alerts

Date Presenter / Topic Register

Maria Trujillo PhD
Principal Scientist, Merck and Co Inc, Kenilworth, NJ

Leveraging a Diabetes QSP Model to Drive Decisions in Target Identification and Validation for Proinsulin to Insulin Conversion Therapy

Owen Jones, PhD
Director DMPK at AstraZeneca

To be determined

Ron Beaver, PhD
Chairman, President, & CEO at Rosa & Co. LLC

To be determined

Thomas Klabunde PhD and/or Britta Göbel, PhD
Sr Director and Global Head Translational Informatics, and Head of Systems Pharmacology EU at Sanofi

To be determined (World Diabetes Day)

Rodrigo Cristofoletti, PhD
Bioequivalence Specialist at the Brazilian Drug Safety and Efficacy Agency

To be determined

Sietse Braakman, PhD
SimBiology Application Engineer at MathWorks

To be determined

"In an evolving field such as QSP, the webinars allow us to keep ahead with that critical edge of knowledge."
—Rebecca A. Baillie, PhD, Principal Scientist & Chief of Staff